ArticleJournal of extracellular vesicles2026
Role of Collection Media on the Biological Activity of Extracellular Vesicles From hTERT-Immortalised Mesenchymal Stromal Cells.
Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Extracellular Vesicles (EVs) from Mesenchymal Stromal Cells (MSCs) are promising cell-free therapeutics due to their ability to modulate immune responses, promote tissue repair and replicate many benefits of their parental cells. However, developing standardised, clinically translatable MSC-EV preparations remains difficult because of biological and technical variability. Factors such as cell source, donor differences, passage number and culture conditions affect EV yield and function, while enrichment methods, purity and media composition further complicate interpretation of EV-specific effects. Although prior studies have explored isolation methods and serum contaminants, the impact of different collection media on EV bioactivity is poorly understood. Here, we used hTERT-immortalised MSCs, which preserve the therapeutic properties of primary MSCs, to minimise cellular variability. EVs were collected in four different xeno-free media, enriched via Tangential Flow Filtration (TFF) and assessed in terms of their anti-inflammatory, anti-fibrotic, gap closure and proliferative potential compared with unconditioned, TFF processed collection media. Our results demonstrate that collection media significantly affect MSC-EV biological and functional properties, highlighting the need to carefully select media for standardised EV production. This study advances standardisation in EV research and supports the development of consistent, clinically relevant MSC-EV products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.